Mode
Text Size
Log in / Sign up

Survey examines diabetes prevalence by disability status and age in US adults

Survey examines diabetes prevalence by disability status and age in US adults
Photo by Towfiqu barbhuiya / Unsplash
Key Takeaway
Note: Survey data shows association between disability, age, and diabetes prevalence; specific results not reported.

This observational analysis used data from the National Health Interview Survey to examine the percentage of US adults aged 18 years or older with diagnosed diabetes, stratified by disability status and age group. The study design was cross-sectional, relying on self-reported survey data. The specific intervention or exposure was disability status combined with age categorization, though no specific comparator group was detailed in the provided information.

Crucially, the main results for the primary outcome—the percentage of adults with diagnosed diabetes—were not reported. The source did not provide the specific prevalence percentages, absolute numbers, effect sizes, p-values, or confidence intervals. The direction of any association was also not reported. No safety, tolerability, or adverse event data were available, as this was a prevalence survey.

Significant limitations stem from the observational, cross-sectional survey design, which can only show associations, not causation. The lack of reported specific results, including prevalence percentages and statistical measures, severely limits interpretation. The funding sources and potential conflicts of interest were not reported. For clinical practice, these findings highlight a descriptive analysis of diabetes prevalence patterns but do not provide actionable quantitative data to guide patient care decisions. The relevance to direct clinical management is therefore minimal without the specific numerical results.

Study Details

EvidenceLevel 5
PublishedJan 2022
View Original Abstract ↓
This report describes the percentage of adults with diabetes by disability status and age group.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.